natgillin/translations-raw huggingface dataset:
The companies therefore did not meet the conditions set in Article 9(5)(e) of the basic Regulation.
Omenjena podjetja tako ne delujejo v skladu s členom 9(5)(e) osnovne uredbe.
Consequently, none of the three exporting producers met the conditions set in Article 9(5) of the basic Regulation.
Posledično noben izmed treh proizvajalcev izvoznikov ni izpolnil pogojev iz člena 9(5) osnovne uredbe.
It was therefore concluded that IT should not be granted to any of the exporting producers to which MET was not granted.
Komisija je tako ugotovila, da ne bo odobrila IT nobenemu izmed proizvajalcev izvoznikov, ki jim ni odobrila MET.
NORMAL VALUE
NORMALNA VREDNOST
Determination of normal value for all exporting producers not granted MET
Določitev normalne vrednosti za vse proizvajalce izvoznike, ki jim ni bil odobren MET
Pursuant to Article 2(7)(a) of the basic Regulation, normal value for the exporting producers not granted MET has to be established on the basis of the prices or constructed value in a market economy third country (analogue country).
Skladno s členom 2(7)(a) osnovne uredbe, se normalna vrednost za proizvajalce izvoznike, ki jim ni bil odobren MET, vzpostavi na temelju cen ali računsko določene vrednosti v tretji državi s tržnim gospodarstvom (analogni državi).
In the notice of initiation, the USA was envisaged as an appropriate market economy third country for the purpose of establishing normal value for the PRC.
V obvestilu o začetku postopka so bile ZDA določene kot ustrezna tretja država s tržnim gospodarstvom z namenom določitve normalne vrednosti za LRK.
Interested parties were invited to comment on this choice.
Zainteresirane strani je Komisija pozvala, naj se izjasnijo glede te izbire.
Three exporting producers contested this choice claiming that the level of economic development, the manufacturing process and the access to raw materials were different in the USA and the PRC.
Trije proizvajalci izvozniki so omenjeno izbiro spodbijali s trditvami, da se raven gospodarske razvitosti, proizvodnega procesa in dostopa do primarnih surovin med ZDA in LRK razlikujejo.
Furthermore, it was argued that the level of competition in the USA was low given that there was only one barium carbonate producer and that the domestic market was protected by anti-dumping duties.
Poleg tega so opozarjali, da je konkurenca v ZDA nizka, saj je na njihovem ozemlju le en proizvajalec barijevega karbonata, domači trg pa je zaščiten s protidampinškimi dajatvami.
South Korea, Russia and India were proposed as alternative analogue countries.
Kot nadomestne analogne države so predlagali Južno Korejo, Rusijo in Indijo.
In any case, the Commission concluded that South Korea was not an appropriate analogue country because it had no domestic source of barite, the most important raw material, and only an insignificant production of barium carbonate.
Komisija je v vsakem primeru ugotovila, da Južna Koreja ni primerna kot analogna država, saj nima domačega vira žarita, najpomembnejše surovine, prav tako ima zanemarljivo proizvodnjo barijevega karbonata.
Furthermore, the Commission rejected Russia as an appropriate analogue country because the barium carbonate produced in Russia was of a significantly lower quality and therefore not comparable to the product produced in the PRC and the Community.
Komisija je kot analogno državo zavrnila tudi Rusijo, saj je tam proizveden barijev karbonat bistveno slabše kakovosti in neprimerljiv s tistim, proizvedenim v LRK in Skupnosti.
The investigation revealed, also that the domestic market in Brazil was small and that the level of protection was higher than in the USA.
Preiskava je pokazala, da je domači trg v Braziliji premajhen, raven zaščite pa višja kot v ZDA.
Brazil was therefore not considered as an appropriate analogue country.
Brazilija zato po mnenju Komisije ni bila primerna kot analogna država.
Furthermore, no evidence was available indicating that any of the countries proposed as an alternative analogue country was more suitable than the USA.
Nadalje, ni bilo nobenega dokaza, da bi bila katera izmed predlaganih držav primernejša od ZDA.
With regard to the USA, it was found that the production volume was substantial and representative with regard to Chinese exports of barium carbonate.
Kar zadeva ZDA, je Komisija ugotovila, da je tamkajšnji obseg proizvodnje precejšen in ustrezen glede na kitajski izvoz barijevega karbonata.
However, it should be noted that even if these differences would affect normal value, they should normally result in a lower normal value in the USA and thus be to the advantage of the Chinese exporting producers.
Vendar je treba omeniti, da bi, četudi bi omenjene razlike vplivale na normalno vrednost, ta bila nižja v ZDA, kar bi bilo v prid kitajskim izvoznikom.
Furthermore, it is recalled that, if necessary, appropriate adjustment can be made.
Nadalje je Komisija spomnila, da so, če bo potrebno, možne ustrezne prilagoditve.
In any case, although local variations of the production processes cannot be excluded, it has not been demonstrated that in any particular country other than the USA the production process would be more comparable to the one used in the PRC.
V vsakem primeru, čeprav lokalnih razlik v proizvodnih procesih ni moč izključiti, ni dokazov, da bi bil proizvodni proces v kateri koli drugi državi razen ZDA primerljivejši s tistim, ki je v uporabi v LRK.
Regarding the competition on the domestic market of the USA, the USA producer was subject to competition from imports from the PRC, Germany and Mexico.
Kar zadeva konkurenco na domačem trgu v ZDA, je tamkajšnji proizvajalec podvržen konkurenci proizvodov iz LRK, Nemčije in Mehike.
Imports of these countries represented approximately 30 % of the market, which was considered substantial.
Uvoz iz teh držav predstavlja približno 30 % trga, kar je precejšen delež.
It was therefore concluded that there was a fair level of competition in the USA.
Komisija je zato ugotovila, da v ZDA obstaja zadostna raven konkurence.
As far as the access to raw materials is concerned, it was found that the USA was, together with the PRC, one of the largest barite producers and had substantial barite reserves.
Kar zadeva dostop do primarnih surovin je bilo ugotovljeno, da so ZDA, skupaj z LRK, eden največjih proizvajalcev barita ter imajo znatne rezerve barita.
It was therefore concluded that the access to the raw material in terms of availability was comparable in the USA and in the PRC.
Zato je Komisija ugotovila, da je dostop do primarnih surovin primerljiv v ZDA in LRK.
In view of the above, it was provisionally concluded that the United States constitutes an appropriate analogue country in accordance with Article 2(7) of the basic Regulation.
Glede na zgoraj omenjeno je bilo ugotovljeno, da so Združene države do nadaljnjega primerna analogna država v skladu s členom 2(7) osnovne uredbe.
Determination of normal value in the analogue country
Določitev normalne vrednosti v analogni državi
Pursuant to Article 2(7)(a) of the basic Regulation, normal value for the exporting producers not granted MET was established on the basis of verified information received from the producer in the analogue country with regard to domestic costs and sales of the like product in the USA market for comparable product types.
V skladu s členom 2(7)(a) osnovne uredbe je normalna vrednost za proizvajalce izvoznike, ki jim ni bil odobren MET, določena na temelju preverjenih podatkov, prejetih od proizvajalca v analogni državi, ob upoštevanju domačih stroškov in prodaje podobnega izdelka na trgu ZDA, za primerljive tipe izdelkov.
Normal value was established by using the methodology outlined in recitals 43 to 47 and 53 to 59.
Normalna vrednost je bila določena z metodologijo, opisano v uvodnih izjavah od (43) do (47) ter (53) do (59).
Domestic sales in the USA were representative, albeit certain product types were not sold in the ordinary course of trade, i.e. were sold at losses.
Prodaja na domačem trgu v ZDA je bila vzorčna, čeprav določeni tipi izdelkov niso bili prodani v normalnem poteku trgovine oz. so bili prodani z izgubo.
For these product types, normal value was constructed in accordance with Article 2(3) and 2(6) of the basic Regulation, by adding a reasonable amount of selling, general and administrative (SG&A) expenses and profit margin to the cost of manufacturing.
Za te tipe izdelkov je bila normalna vrednost sestavljena v skladu s členom 2(3) in 2(6) osnovne uredbe, z dodajanjem razumnega števila prodajnih, splošnih in administrativnih (SG&A) stroškov ter stopnje dobička k proizvodnim stroškom.
Since domestic sales of the product concerned were representative, the company's SG&A were considered reliable and were used.
Ker je domača prodaja zadevnega izdelka vzorčna, se SG&A podjetja šteje za zanesljivega in ga je Komisija uporabila.
As far as the profit margin is concerned, the company's own profit margin realised for domestic sales of the product concerned could not be used because these sales were overall made at a loss.
Lastna stopnja dobička omenjenega podjetja pa ni mogla biti uporabljena, ker je bila celotna prodaja opravljena z izgubo.
Since no other producer in the US cooperated, the Commission used the profit margin applicable to the production and sales of the same general category of products in accordance with Article 2(6)(b) of the basic Regulation.
Ker noben drug proizvajalec iz ZDA ni bil pripravljen sodelovati, je Komisija uporabila stopnjo dobička, ki se uporablja za proizvodnjo in prodajo enake splošne kategorije izdelkov, v skladu s členom 2(6)(b) osnovne uredbe.
For all other product types, normal value was established as the weighted average domestic sales price to unrelated customers by the cooperating producer in the USA, adjusted as described below.
Za vse ostale tipe izdelkov je bila normalna vrednost določena kot domača tehtna povprečna prodajna cena sodelujočega ameriškega proizvajalca za neodvisne stranke, prilagojena na spodaj opisani način.
Determination of normal value for exporting producers granted MET
Določitev normalne vrednosti za proizvajalce izvoznike, ki jim je bil odobren MET
As far as the determination of normal value is concerned, the Commission first established, for each cooperating exporting producer, whether its total domestic sales of barium carbonate were representative in comparison with its total export sales to the Community.
Kar zadeva določitev normalne vrednosti, je Komisija najprej za vsakega sodelujočega proizvajalca izvoznika določila, ali so njegove domače prodaje barijevega karbonata reprezentančne v primerjavi s celotno izvozno prodajo v Skupnost.
In accordance with Article 2(2) of the basic Regulation, domestic sales were considered representative when the total volume of such sales represented at least 5 % of the total export sales volume of the producer to the Community.
V skladu s členom 2(2) osnovne uredbe je domača prodaja veljala za reprezentančno, če je celoten obseg takšne prodaje predstavljal najmanj 5 % celotne izvozne prodaje proizvajalca v Skupnost.
On this basis, for both exporting producers overall domestic sales of the product concerned during the IP were made in representative quantities.
Na tej osnovi je za oba proizvajalca izvoznika celotna domača prodaja zadevnega izdelka v obdobju preiskave podana v reprezentančnih številih.
The Commission subsequently identified those types of the product concerned sold domestically that were identical or directly comparable with the types sold for export to the Community.
Komisija je posledično določila tiste tipe zadevnega izdelka v domači prodaji, ki so bili identični ali neposredno primerljivi s tipi izdelka, prodanimi za izvoz v Skupnost.
For each type sold by the exporting producers on their domestic markets and found to be directly comparable with the type of barium carbonate sold for export to the Community, it was established whether domestic sales were sufficiently representative for the purposes of Article 2(2) of the basic Regulation.
Za vsak tip, ki so ga prodali proizvajalci izvozniki na svojih domačih trgih in za katerega je bilo ugotovljeno, da je neposredno primerljiv s tipom barijevega karbonata, prodanega za izvoz v Skupnost, je bilo določeno, ali domača prodaja velja za dovolj vzorčno za namene člena 2(2) osnovne uredbe.
Domestic sales of a particular type of barium carbonate were considered sufficiently representative when the total domestic sales volume of that type during the IP represented 5 % or more of the total sales volume of the comparable type of barium carbonate exported to the Community.
Domača prodaja določenega tipa barijevega karbonata se je štela za zadosti vzorčno, če je celoten obseg domače prodaje tega tipa v obdobju preiskave predstavljal 5 ali več odstotkov celotnega obsega prodaje primerljivega tipa barijevega karbonata, izvoženega v Skupnost.
As a result of this analysis, all product types but one, were sold in representative quantities.
Kot rezultat teh raziskav so bili vsi tipi izdelka, razen enega, prodani v reprezentančnih količinah.
The Commission subsequently examined whether the domestic sales of each type of barium carbonate, sold domestically in representative quantities could be regarded as having been made in the ordinary course of trade in accordance with Article 2(4) of the basic Regulation, by establishing the proportion of profitable sales to independent customers of the barium carbonate type in question.
Komisija je naknadno preverila, ali lahko domačo prodajo vsakega tipa barijevega karbonata, prodanega na domačem trgu in v reprezentančnih količinah, šteje kot navaden potek trgovine v skladu s členom 2(4) osnovne uredbe, z določitvijo skladnosti donosne prodaje zadevnega tipa barijevega karbonata neodvisnim strankam.
Domestic sales transactions were considered profitable where the unit price of a specific product type was equal to or above the cost of production.
Domače prodajne transakcije so veljale za donosne, če je bila cena za enoto določenega tipa izdelka enaka ali višja od stroškov proizvodnje.
Cost of production for each product type sold on the domestic market during the IP was therefore determined.
Strošek proizvodnje za vsak tip izdelka, prodanega na domačem trgu v obdobju preiskave, je bil tako določen.
The company argued that after it bought its production lines it invested substantial amounts in repairs before test production and finally normal production started.
Podjetje je zahtevo utemeljevalo s pojasnilom, da je, potem ko je kupilo proizvodne linije, vložilo dodatna sredstva v popravila, preden se je začela poskusna, nato pa še redna proizvodnja.
It was claimed that the average start-up phase for both production lines was 11 months and that normal production would have started eight months after beginning of the IP.
Trdilo je, da je povprečna zagonska faza za obe proizvodni liniji znašala 11 mesecev ter da se je redna proizvodnja začela 8 mesecev po začetku obdobja preiskave.
In contrast to what was claimed by this exporting producer, it was found that the monthly production and sales volumes were at the same level during the entire IP and in some cases even exceeded the monthly volumes produced and sold in the period where allegedly normal capacity utilisation rates were reached.
V nasprotju s trditvami proizvajalca izvoznika je Komisija ugotovila, da sta bila mesečna proizvodnja in obseg prodaje na enaki ravni ves čas obdobja preiskave in da sta v nekaterih primerih celo presegla mesečne obsege, proizvedene in prodane v obdobju, ko naj bi bile dosežene stopnje normalnega izkoristka zmogljivosti.
The substantial sales volumes throughout the entire IP did not point to sales from a mere test production.
Dodatni obsegi prodaje skozi celotno obdobje preiskave niso kazali samo na poskusno proizvodnjo.
It was consequently concluded that the company produced at normal capacity utilisation rates throughout the entire IP.
Posledično je Komisija ugotovila, da je podjetje proizvajalo z normalno stopnjo izkoristka zmogljivosti ves čas trajanja preiskave.
Furthermore, the company did not show that during the alleged start-up phase, unit production costs were higher than in the period where allegedly normal capacity utilisation rates were reached.
Nadalje, podjetje ni dokazalo, da so bili v času domnevne zagonske faze stroški proizvodnje na enoto višji kot v obdobju, ko naj bi doseglo normalne stopnje izkoristka zmogljivosti.
In any case, even if costs would have been higher, this would not have been a consequence of lower production volumes as evidenced above.
V vsakem primeru, četudi bi bili stroški višji, to ne bi imelo za posledico nižjih obsegov proizvodnje, kar je dokazano zgoraj.
It was consequently concluded that the claim for an adjustment with regard to start-up costs was contradictory and not confirmed by any evidence and was therefore rejected.
Komisija je posledično ugotovila, da je zahteva po prilagoditvi glede zagonskih stroškov protislovna in da ni bila podkrepljena z nobenim dokazom, zato jo je zavrnila.
The same producer claimed that the depreciation method used by the company for ‘investments on fixed assets’ did not reasonably reflect the costs associated with the production and sale of the product concerned.
Isti proizvajalec je trdil, da depreciacijska metoda, ki jo je podjetje uporabilo za „naložbe v stalna sredstva“, ni razumno odražala stroškov, povezanih s proizvodnjo in prodajo zadevnega izdelka.
The investments made corresponded to the initial repair costs of the production lines after their acquisition and were accounted for in one financial year, given that the company considered that the useful life of the repaired assets would be less than one year.
Naložbe so se ujemale z začetnimi stroški popravil proizvodnih linij po njihovi pridobitvi in so bile obračunane v enem finančnem letu, ob tem, da je podjetje domnevalo, da bo uporabna življenjska doba popravljenega premoženja manj kot eno leto.
The company expected to then make further investments after this period.
Podjetje je po tem obdobju načrtovalo nadaljnje naložbe.
Given, however, that no further repairs were needed to the production lines, the actual lifetime of the investments was longer than originally expected.
Ker pa nadaljnja popravila proizvodnih linij niso bila več potrebna, je bila dejanska življenjska doba naložb daljša od prvotno pričakovane.
The company claimed that the depreciation period should thus be adapted in accordance with the economic reality and the costs as booked in the accounts adjusted accordingly pursuant to Article 2(5) of the basic Regulation.
Podjetje je trdilo, da bi bilo torej treba depreciacijsko obdobje sprejeti v skladu z ekonomsko stvarnostjo in stroški, kot je zapisano v računovodski dokumentaciji, prilagojeno v skladu s členom 2(5) osnovne uredbe.
With regard to the above claim, it is considered that higher than normal repair expenses in the first year of the ownership of used equipment is not unusual and to book such higher costs in the first year corresponds to normal accounting practices.
Glede na zgoraj navedeno zahtevo se šteje, da stroški popravil, višji od normalnih, v prvem letu uporabe rabljene opreme, niso neobičajni, vpis takšnih stroškov v računovodsko evidenco pa je v skladu z običajno računovodsko prakso.
The methodology chosen by the company was therefore not unreasonable, but corresponded to normal practice.
Metodologija, ki jo je uporabilo podjetje, torej ni nerazumna, temveč je v skladu z običajno prakso.
The fact that no further repair cost incurred afterwards does not justify departing from normal accounting practice.
Dejstvo, da potem ni bilo dodatnih stroškov popravila, ne opravičuje odstopanja od običajne računovodske prakse.
The company's claim to adjust costs in this regard was therefore not warranted and was rejected.
Zahteva podjetja po prilagoditvi stroškov v tem smislu je torej neutemeljena in jo je Komisija zavrnila.
The other exporting producer claimed that the value of a by-product (sulphur) should be deducted from the cost of production of the product concerned.
Drugi proizvajalec izvoznik je zahteval, da bi morali vrednost stranskega proizvoda (žvepla) odšteti od proizvodnih stroškov zadevnega izdelka.
Sulphur is further processed from a gas (H2S) which is set free automatically when producing barium carbonate.
Žveplo poleg tega pridobivajo iz plina (H2S), ki se samodejno sprošča ob proizvodnji barijevega karbonata.
However, the company had no technical means to measure the quantity of gas used in the production of sulphur and could therefore not quantify its claim.
Vendar podjetje ni imelo tehničnih namenov izmeriti količino plina, uporabljenega pri proizvodnji žvepla, in torej ni moglo določiti količine v svoji zahtevi.
Furthermore, in the company's accounting system, sulphur and the product concerned were treated as two separate products and the costs of producing barium carbonate were established without taking into account the value of sulphur.
Nadalje, v računovodski dokumentaciji podjetja sta bila žveplo in zadevni izdelek obravnavana kot ločena izdelka, stroški proizvodnje barijevega karbonata pa so bili določeni brez upoštevanja vrednosti žvepla.
On this basis, the claim was provisionally rejected.
Na tej osnovi je bila zahteva začasno zavrnjena.
As mentioned in recital 46, the proportion of profitable sales to independent customers in the domestic market of the product type in question was established.
Kot je omenjeno v uvodni izjavi (45), je bilo določeno razmerje donosne prodaje zadevnega tipa izdelka neodvisnim strankam na domačem trgu.
In cases where the sales volume of the barium carbonate type, sold at a net sales price equal to or above the calculated cost of production, represented more than 80 % of the total sales volume of that type, and where the weighted average price of that type was equal to or above the cost of production, normal value was based on the actual domestic price, calculated as a weighted average of the prices of all domestic sales of that type made during the IP, irrespective of whether these sales were profitable or not.
V primerih, ko je obseg prodaje tipa barijevega karbonata, prodanega po neto prodajnih cenah, enakih ali višjih od izračunanih stroškov proizvodnje, znašal več kot 80 % celotnega obsega prodaje tega tipa, in ko je bilo tehtno povprečje cen tega tipa enako ali nad stroški proizvodnje, je normalna vrednost temeljila na dejanski domači ceni, izračunani kot tehtano povprečje cen celotne domače prodaje tega tipa v obdobju preiskave, ne glede na to, ali je bila ta prodaja donosna ali ne.
In cases where the volume of profitable sales of the barium carbonate type represented 80 % or less of the total sales volume of that type, or where the weighted average price of that type was below the cost of production, normal value was based on the actual domestic price, calculated as a weighted average of profitable sales of that type only, provided that these sales represented 10 % or more of the total sales volume of that type.
V primerih, ko je obseg donosne prodaje tipa barijevega karbonata predstavljal 80 ali manj odstotkov celotnega obsega proizvodnje tega tipa, ali kjer je bilo tehtano povprečje donosne prodaje tega tipa nižje od stroškov proizvodnje, je normalna vrednost temeljila na dejanski domači ceni, izračunani kot tehtano povprečje donosnih prodaj samo tega tipa, pod pogojem, da so te prodaje predstavljale 10 ali več odstotkov celotnega obsega prodaje tega tipa.
In cases where the volume of profitable sales of any product type represented less than 10 % of the total sales volume of that type, it was considered that this particular type was sold in insufficient quantities for the domestic price to provide an appropriate basis for the establishment of the normal value.
V primerih, kjer obseg donosne prodaje katerega koli tipa znaša manj kot 10 % celotnega obsega prodaje tega tipa, se šteje, da je bil ta določen tip prodan v nezadostnih količinah za domačo ceno, za zagotovitev primerne podlage za določitev normalne vrednosti.
As a result of the above analysis, it was found that all product types, except one, were sold in the ordinary course of trade by reason of price.
Kot rezultat zgoraj navedenih analiz je Komisija ugotovila, da so bili vsi tipi izdelka, razen enega, prodani v normalnem poteku trgovine zaradi cene.